Yttrium‐90 radiation segmentectomy for hepatic metastases: A multi‐institutional study of safety and efficacy

This study assessed the outcomes of Yttrium‐90 (90Y) radiation segmentectomy for hepatic metastases unamenable to resection or ablation.

[1]  Y. Bekki,et al.  Evolution of Surgical Management of Colorectal Liver Metastasis , 2020, Digestive Disease Interventions.

[2]  Versione,et al.  Common Terminology Criteria for Adverse Events , 2020, Definitions.

[3]  F. Aucejo,et al.  Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience , 2019, Surgical Endoscopy.

[4]  R. Bale,et al.  Local Treatment of Breast Cancer Liver Metastasis , 2019, Cancers.

[5]  I. Chervoneva,et al.  A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis. , 2019, Radiology.

[6]  W. Bechstein,et al.  Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  Matthew S. Johnson,et al.  90Y Radioembolization for Hepatic Malignancy in Patients with Previous Biliary Intervention: Multicenter Analysis of Hepatobiliary Infections. , 2018, Radiology.

[8]  R. van Hillegersberg,et al.  Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison. , 2018, European journal of cancer.

[9]  M. Abecassis,et al.  Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma. , 2018, Radiology.

[10]  B. Geller,et al.  Safety and initial efficacy of radiation segmentectomy for the treatment of hepatic metastases​. , 2018, Journal of gastrointestinal oncology.

[11]  M. Gonen,et al.  Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control. , 2017, Journal of vascular and interventional radiology : JVIR.

[12]  J. Titano,et al.  Radiation Segmentectomy versus Selective Chemoembolization in the Treatment of Early-Stage Hepatocellular Carcinoma. , 2018, Journal of vascular and interventional radiology : JVIR.

[13]  F. Miller,et al.  Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma , 2018, Abdominal Radiology.

[14]  J. Engstrand,et al.  Colorectal cancer liver metastases – a population-based study on incidence, management and survival , 2018, BMC Cancer.

[15]  T. Treasure,et al.  Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial , 2017 .

[16]  V. Gebski,et al.  First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials , 2017, The Lancet. Oncology.

[17]  E. Ziv,et al.  Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases , 2017, Oncotarget.

[18]  R. Adam,et al.  Liver Metastases From Breast Cancer: What Role for Surgery? Indications and Results , 2017, Clinical breast cancer.

[19]  S. Kwan,et al.  Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study. , 2017, Journal of vascular and interventional radiology : JVIR.

[20]  J. Titano,et al.  Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study. , 2017, Radiology.

[21]  E. Petre,et al.  Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease , 2017, Visceral Medicine.

[22]  Kecheng Xu,et al.  Comparison between cryoablation and irreversible electroporation of rabbit livers at a location close to the gallbladder , 2016, Radiology and oncology.

[23]  Thomas G. Walker,et al.  Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions. , 2017, Journal of vascular and interventional radiology : JVIR.

[24]  J Ricke,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  A. Benson,et al.  90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study , 2016, The Journal of Nuclear Medicine.

[26]  H. Jang,et al.  Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review , 2016, Oncotarget.

[27]  D. Sze,et al.  Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival , 2016, CardioVascular and Interventional Radiology.

[28]  M. Gonen,et al.  Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center. , 2016, Radiology.

[29]  E. Krenning,et al.  ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site , 2016, Neuroendocrinology.

[30]  D. Winter,et al.  Radiofrequency ablation for neuroendocrine liver metastases: a systematic review. , 2015, Journal of vascular and interventional radiology : JVIR.

[31]  S. Kwan,et al.  Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity. , 2014, Journal of vascular and interventional radiology : JVIR.

[32]  M. Abecassis,et al.  Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology‐pathology correlation and survival of radiation segmentectomy , 2014, Hepatology.

[33]  W. Jarnagin,et al.  Colorectal cancer patients with oligometastatic liver disease: what is the optimal approach? , 2013, Oncology.

[34]  R. Scolyer,et al.  Liver resection for metastatic melanoma: Equivalent survival for cutaneous and ocular primaries , 2013, Journal of surgical oncology.

[35]  Luigi Solbiati,et al.  Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. , 2012, Radiology.

[36]  L. Filippi,et al.  Radioembolisation with 90Y-labelled resin microspheres in the treatment of liver metastasis from breast cancer , 2012, European Radiology.

[37]  H. Amthauer,et al.  Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal Metastases , 2012, CardioVascular and Interventional Radiology.

[38]  A. Benson,et al.  Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. , 2011, International journal of radiation oncology, biology, physics.

[39]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[40]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[41]  M. Choti,et al.  Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement , 2006, Annals of Surgical Oncology.

[42]  N. Petrelli,et al.  Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Kenneth Hess,et al.  Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases , 2004, Annals of surgery.

[44]  Michael A. Choti,et al.  Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases , 2002, Annals of surgery.

[45]  W. Enker,et al.  Liver resection for colorectal metastases. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  L H Blumgart,et al.  Treatment of colorectal cancer: hepatic metastasis. , 1996, Seminars in surgical oncology.

[47]  B. Nordlinger,et al.  Surgical resection of liver metastases from colo-rectal cancers. , 1987, International surgery.